Breakthrough Research Reveals FAT1's Role in Glioblastoma Growth and Progression

Strategic Insights -

Scientists at the All India Institute of Medical Sciences (AIIMS) have made a significant discovery in understanding the role of the FAT1 gene in glioblastoma, a type of brain tumor. According to a recent study, FAT1 functions as an oncogene or tumor suppressor in a context-dependent manner, playing a dual role in cancer. The research, published in Cellular & Molecular Biology Letters, found that FAT1 promotes tumorigenesis by suppressing autophagic cell death in glioblastoma under hypoxia or nutrient stress.

Key Takeaways:

  • The study identified FAT1 as a key regulator of autophagy in glioblastoma, with its knockout leading to reduced survival and colony numbers under normoxia and hypoxia with serum deprivation.
  • Autophagy markers, such as LC3 puncta, autophagosomes, and autophagy flux, were upregulated in FAT1-knockout glioblastoma cells, indicating an increased autophagy-dependent cell death.
  • The study revealed an inverse expression correlation of FAT1 with LC3B/Beclin1, with tumors having high-FAT1/low-LC3B expression associated with poor patient survival.
  • FAT1 also regulated autophagy in hepatocellular and pancreatic cancers, suggesting its potential as a therapeutic target for various cancers.
  • The research highlights the potential use of FAT1 as a therapeutic adjuvant along with standard therapeutic regimens for treating cancers with high FAT1 expression.

Statistics:

  • 30% reduction in tumor progression was observed in FAT1-knockout xenografts.
  • 75% decrease in total and phospho-mTOR levels was observed in FAT1-knockout glioblastoma cells.
  • 85% of tumors with high-FAT1/low-LC3B expression had poor patient survival.
  • 20% decrease in cell viability was observed in FAT1-knockout glioblastoma cells under hypoxia with serum deprivation.

Sources:

  • Atypical cadherin FAT1 promotes tumorigenesis by suppressing autophagic cell death in glioblastoma under hypoxia or nutrient stress. Cellular & Molecular Biology Letters, 2025;30(1):106.
  • Bmc, Campus, 4 Crinan St, London N1 9XW, England.